Grants per year
Personal profile
Education/Academic qualification
Medicine and Surgery, MBBCh, University of Alexandria
… → 2009
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Molecular mechanism underlying clonal expansion of hematopoietic stem cells
Liu, Y. (PD/PI), Abaza, Y. (Co-Investigator), Altman, J. K. (Co-Investigator) & Bartom, E. T. (Co-Investigator)
National Heart, Lung, and Blood Institute
4/1/24 → 3/31/28
Project: Research project
-
Prot #M23‑477: A Phase 1 First‑In‑Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV‑787 in Adult Subjects with Acute Myeloid Leukemia (AML)
Abaza, Y. (PD/PI)
12/7/23 → 12/7/27
Project: Research project
-
Prot #CA-4948-102: A Phase 1/2a, Open-label Dose Escalation and Cohort Expansion Study of Orally Administered ca-4948 (IRAK4I) as a Monotherapy in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome and in Combination with Azacitidine or
Abaza, Y. (PD/PI)
Catalyst Clinical Research, LLC, Curis, Inc.
3/7/23 → 3/7/26
Project: Research project
-
Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11
Gao, J., Santana-Santos, L., Fu, L., Alvey, E., Chen, Q., Wolniak, K., Xia, Z., Aqil, B., Behdad, A., Ji, P., Sukhanova, M., Abaza, Y., Altman, J. K., Chen, Y. H. & Lu, X., Jun 2024, In: European Journal of Haematology. 112, 6, p. 964-974 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers
Abaza, Y., Winer, E. S., Murthy, G. S. G., Shallis, R. M., Matthews, A. H., Badar, T., Geramita, E. M., Kota, V. K., Swaroop, A., Doukas, P., Bradshaw, D., Helenowski, I. B., Liu, Y., Zhang, H., Im, A., Litzow, M. R., Perl, A. E., Atallah, E. & Altman, J. K., Apr 2024, In: American Journal of Hematology. 99, 4, p. 606-614 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Badar, T., Nanaa, A., Atallah, E., Shallis, R. M., Guilherme, S. D. C. C., Goldberg, A. D., Saliba, A. N., Patel, A., Bewersdorf, J. P., DuVall, A. S., Bradshaw, D., Abaza, Y., Murthy, G. S. G., Palmisiano, N., Zeidan, A. M., Kota, V. & Litzow, M. R., Dec 2024, In: Blood cancer journal. 14, 1, 32.Research output: Contribution to journal › Letter › peer-review
Open Access7 Scopus citations -
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia
Mohamed, A., Gao, J., Chen, Y. H., Abaza, Y., Altman, J., Jennings, L., Vormittag-Nocito, E., Sukhanova, M., Lu, X. & Chen, Q., Jul 2024, In: Human pathology. 149, p. 66-74 9 p.Research output: Contribution to journal › Article › peer-review
-
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era
Patel, A. A., Yoon, J. J., Johnston, H., Davidson, M. B., Shallis, R. M., Chen, E. C., Burkart, M., Oh, T. S., Iyer, S. G., Madarang, E., Muthiah, C., Gross, I., Dean, R., Kassner, J., Viswabandya, A., Madero-Marroquin, R., Rampal, R. K., Murthy, G. S. G., Bradley, T. & Abaza, Y. & 5 others, , Jul 9 2024, In: Blood Advances. 8, 13, p. 3468-3477 10 p.Research output: Contribution to journal › Article › peer-review
Open Access